Cigna Corp. (CI) Tops Q4 EPS by 20c, Beats on Revenue; Offers FY26 Guidance
Tweet
Share
E-mail
Get Alerts CI Hot Sheet
Price: $282.52 -1.31%
Revenue Growth %: +4.2%
Financial Fact:
Shareholders' net income: 1.78
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Shareholders' net income: 1.78
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q4 EPS of $8.08, $0.20 better than the analyst estimate of $7.88. Revenue for the quarter came in at $72.47 billion versus the consensus estimate of $70.31 billion.
GUIDANCE:
Cigna Corp. sees FY2026 EPS of $30.25, versus the consensus of $30.34. Cigna Corp. sees FY2026 revenue of $280 billion, versus the consensus of $282.4 billion.
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
